Back to Journals » Clinical, Cosmetic and Investigational Dermatology » Volume 16

Guselkumab, Risankizumab, and Tildrakizumab in the Management of Hidradenitis Suppurativa: A Review of Existing Trials and Real-Life Data

Total article views   HTML views PDF downloads Totals
2,989 Dovepress* 2,361+ 80 2,441
PubMed Central* 628 224 852
Totals 2,989 304 3,293
*Since 18 September 2023

View citations on PubMed Central and Google Scholar